Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist PegvisomantPeter Trainer, John A. Scarlett, William M Drake et al.|New England Journal of Medicine|2000Cited by 874
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonistAart Jan van der Lely, Michael O. Thorner, R. Kent Hutson et al.|The Lancet|2001Cited by 643
Growth Hormone (GH) Replacement Therapy in Adult-Onset GH Deficiency: Effects on Body Composition in Men and Women in a Double-Blind, Randomized, Placebo-Controlled TrialAndrew R. Hoffman, Mary Lee Vance, Joyce Kuntze et al.|The Journal of Clinical Endocrinology & Metabolism|2004Cited by 185
Growth Hormone Research Society perspective on the development of long-acting growth hormone preparationsJens Sandahl Christiansen, Kevin C.J. Yuen, Laurie E. Cohen et al.|European Journal of Endocrinology|2016Cited by 144
Influence of matrix on concentrations of somatotropin measured in serum with commercial immunoradiometric assays.Robin A. Felder, Michael O. Thorner, Reinhard W. Holl et al.|Clinical Chemistry|1989Cited by 35